Can administrative data be used to measure chemotherapy side effects?

Area of Science:

• Health economics
• Pharmacoeconomics
• Clinical data analysis

Background:

• Economic evaluations in healthcare often rely on clinical trial or observational study data.
• Chemotherapy side effects present challenges when using routine data for economic assessments.
• Administrative data offers potential advantages for populating economic models due to accessibility and generalizability.

Purpose of the Study:

• To evaluate the utility of administrative data for identifying chemotherapy side effects in economic modeling.
• To compare chemotherapy side effects recorded in administrative data with patient self-reported events.
• To discuss the limitations of administrative data for capturing clinical events in economic evaluations.

Main Methods:

• An observational cohort study utilizing linked administrative data.
• Comparison of chemotherapy side effects identified in administrative data versus patient self-reports.
• Qualitative discussion on the implications for economic modeling.

Main Results:

• Administrative data may not fully capture the spectrum or accuracy of chemotherapy side effects reported by patients.
• Discrepancies exist between administrative records and patient-reported adverse events.
• The ease of access to administrative data is contrasted with its limitations in clinical event identification.

Conclusions:

• While attractive for economic modeling, administrative data requires careful validation for clinical event accuracy, particularly for adverse events like chemotherapy side effects.
• Limitations in administrative data necessitate a cautious approach to their use in populating economic models.
• Further research is needed to reconcile administrative data with patient-reported outcomes for robust economic evaluations.